Clik here to view.
When is it appropriate to describe CMT symptoms as mild?
From a cursory internet search, it’s easy to find many articles that describe certain Charcot-Marie-Tooth (CMT) symptoms as mild. Some even refer to types of CMT that way. For years, I didn’t think too...
View ArticleClik here to view.
CMTA awards more than $225K to develop CMT2E treatments
The Charcot-Marie-Tooth Association (CMTA) has given a $225,483 award to support the development of treatments for Charcot-Marie-Tooth disease type 2E (CMT2E). The work is also being supported by the...
View ArticleClik here to view.
Considering what it takes to be a bodybuilder with CMT
John Nixon, like me, has Charcot-Marie-Tooth disease (CMT). Based on how he tells his story, the CMT symptoms he’s dealt with since childhood are more severe than mine. When we spoke a couple of weeks...
View ArticleClik here to view.
Cellular response to stress links different types of CMT2, per study
Many of the mutated proteins that cause the different forms of Charcot-Marie-Tooth disease type 2 (CMT2) tend to go to a point in nerve cells, or neurons, called stress granules. There, upon stress,...
View ArticleClik here to view.
I’m learning that the answer is not the destination, but the journey
A few weeks ago, I spoke with John Nixon, a bodybuilder with Charcot-Marie-Tooth disease (CMT), about his experiences in the sport. During our video chat, Nixon highlighted one key reason for his...
View ArticleClik here to view.
How cold weather affects my hand strength with CMT
It’s getting colder in my corner of the United States. I can feel it in my hands. For me, it’s not just the sensation of the chilly atmosphere nipping at my bare skin. My hand strength also seems to be...
View ArticleClik here to view.
Repairs done by Schwann cells help limit nerve damage in CMT: Study
In Charcot-Marie-Tooth disease (CMT), a type of support cell called Schwann cells help to repair nerve injury to limit the severity of the disease, a new study suggests. The finding suggests that...
View ArticleClik here to view.
Pharnext working toward applications for PXT3003 approval
Pharnext is analyzing clinical trial data that could support applications to approve PXT3003, its therapy candidate for people with Charcot-Marie-Tooth type 1A (CMT1A), in the U.S. and Europe. “We...
View ArticleClik here to view.
Learning to appreciate diversity in the disability community
There’s no road map of what to expect with a disability or chronic condition such as my disease, Charcot-Marie-Tooth (CMT). Sure, I have typical symptoms to consider: weak hands and ankles, foot drop,...
View ArticleClik here to view.
CMT-causing mutations linked to abnormal NF-L glycosylation
Some mutant forms of neurofilament light (NF-L) linked to Charcot-Marie-Tooth disease (CMT) show abnormal glycosylation, a type of protein modification, which may compromise how they support nerve...
View ArticleClik here to view.
Upending the models of traditional masculinity to include weakness
If being a man truly meant being as swift as a coursing river, with all the force of a great typhoon, with all the strength of a raging fire, all while being as mysterious as the dark side of the moon,...
View ArticleClik here to view.
Foot surgery eases walking-related pain in CMT: Small study
Foot surgery may help reduce pain during walking and correct the way people with Charcot–Marie–Tooth disease (CMT) stand, a brief report by researchers in Italy suggests. While foot surgery may not...
View ArticleClik here to view.
CMT Foundation joins nurse on solo sail to raise awareness
The CMT Research Foundation is joining Jenny Decker, a nurse with Charcot-Marie-Tooth disease (CMT) who last summer set sail on a solo trip around the world to raise awareness about the disease. The...
View ArticleClik here to view.
We need more conversations about disability and employment
At my day job, I work in a midsized public library system, which I really enjoy. I help folks find books and other resources and work to make them feel more connected to their community. We don’t...
View Article
